Letter from M. Carr to various Alpha Therapeutic officials summarising the PMA/FDA Meeting on AIDS on 9 June 1983. Meeting discussed plasma from known/suspected AIDS victims and notes that companies will try and present an industry proposal for handling situation where contaminated plasma is used in manufactured product. Also addresses donor screening/donor selection in relation to AIDS.